Hs Lee

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

Richard Pazdur, Robert Justice, Nitin Mehrotra, 2015, Clinical Cancer Research.

U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia

R. Pazdur, R. Justice, C. Ko, 2014, Clinical Cancer Research.

FDA analysis of MRD data in hematologic malignancy applications.

Amy McKee, R. Pazdur, A. Farrell, 2017 .

U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia

R. Pazdur, R. Justice, C. Ko, 2014, Clinical Cancer Research.